NHS will not pay for 'life-changing' migraine drug A migraine drug that has been described as "life changing" by some patients will not be made available on the NHS outside of Scotland.
Erenumab - also known by the name Aimovig - is one of the first bespoke migraine drugs in decades and has been described by doctors as a "huge deal".
But the body that approves new drugs said there were doubts whether it was good enough or worth the money. BBC News
See also:
Erenumab - also known by the name Aimovig - is one of the first bespoke migraine drugs in decades and has been described by doctors as a "huge deal".
But the body that approves new drugs said there were doubts whether it was good enough or worth the money. BBC News
See also:
No comments:
Post a Comment